A probabilistic method for the estimation of residual risk in donated blood.

about

Selection strategies for newly registered blood donors in European countries.Residual risk and waste in donated blood with pooled nucleic acid testing.

P2860

Q39306032-EBBF2A8B-D90B-4F4B-A4C0-E5F6AEAC1053 Q39527094-0006C7C8-8CCB-4BC4-8C97-99F94F4FD800

P2860

A probabilistic method for the estimation of residual risk in donated blood.

Item

http://www.wikidata.org/entity/Q42221214

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

A probabilistic method for the estimation of residual risk in donated blood.

@en

A probabilistic method for the estimation of residual risk in donated blood.

@nl

type

Item

label

A probabilistic method for the estimation of residual risk in donated blood.

@en

A probabilistic method for the estimation of residual risk in donated blood.

@nl

prefLabel

A probabilistic method for the estimation of residual risk in donated blood.

@en

A probabilistic method for the estimation of residual risk in donated blood.

@nl

P1476

A probabilistic method for the estimation of residual risk in donated blood.

@en

P2093

Anthony D Slonim

http://www.w3.org/2001/XMLSchema#string

Douglas R Bish

http://www.w3.org/2001/XMLSchema#string

Ebru K Bish

http://www.w3.org/2001/XMLSchema#string

Prasanna K Ragavan

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus infection--natural history and clinical consequences

Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models.

Validation of laboratory-developed molecular assays for infectious diseases

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Chapter 9: options for summarizing medical test performance in the absence of a "gold standard".

Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe.

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations.

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

P304

620-635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BIOSTATISTICS/KXU017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan L Stramer

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262015769

http://www.w3.org/2001/XMLSchema#string

P698

24784858

http://www.w3.org/2001/XMLSchema#string

A probabilistic method for the estimation of residual risk in donated blood.

about

P2860

P2860

A probabilistic method for the estimation of residual risk in donated blood.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698